
CAS 1510829-06-7
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
7 produits concernés.
Vecabrutinib
CAS :Formule :C22H24ClF4N7O2Degré de pureté :99%Couleur et forme :SolidMasse moléculaire :529.9183Vecabrutinib
CAS :Produit contrôléFormule :C22H24ClF4N7O2Couleur et forme :NeatMasse moléculaire :529.918Vecabrutinib
CAS :<p>Vecabrutinib is a Toll-like receptor (TLR) modulator that binds to TLRs and blocks the activation of TLRs, thereby inhibiting the production of pro-inflammatory cytokines. Vecabrutinib has been shown to be effective against chronic lymphocytic leukemia, as well as in other cancers such as lung cancer and melanoma. Vecabrutinib has also been shown to have anti-inflammatory effects in mice with autoimmune diseases. This drug inhibits the activation of TLR4, which is involved in the initiation of immune responses against infectious agents, tumor cells, or foreign materials. It was also found to be effective at inhibiting symptoms of arthritis and reducing pain associated with inflammatory diseases. The effective dose for this drug is not yet known.</p>Formule :C22H24ClF4N7O2Degré de pureté :Min. 95%Masse moléculaire :529.92 g/molVecabrutinib
CAS :<p>Vecabrutinib (SNS-062) is a potent and noncovalent BTK and ITK inhibitor (Kd: 0.3 nM and 2.2 nM, respectively). Vecabrutinib displays an IC50 of 24 nM for ITK.</p>Formule :C22H24ClF4N7O2Degré de pureté :99.74%Couleur et forme :SolidMasse moléculaire :529.92





